Cargando…

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension

Cannabidiol (CBD) is a plant-derived compound with antioxidant and anti-inflammatory properties. Pulmonary hypertension (PH) is still an incurable disease. CBD has been suggested to ameliorate monocrotaline (MCT)-induced PH, including reduction in right ventricular systolic pressure (RVSP), a vasore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzyżewska, Anna, Baranowska-Kuczko, Marta, Jastrząb, Anna, Kasacka, Irena, Kozłowska, Hanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143935/ https://www.ncbi.nlm.nih.gov/pubmed/35630804 http://dx.doi.org/10.3390/molecules27103327

Ejemplares similares

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2021)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of K(Ca)2.x and K(Ca)3.1 Channels
por: Kloza, Monika, et al.
Publicado: (2019)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
por: Mińczuk, Krzysztof, et al.
Publicado: (2022)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
por: Jastrząb, Anna, et al.
Publicado: (2019)

Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2014)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
por: Polonio, Igor Bastos, et al.
Publicado: (2014)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
por: Jin, Haifeng, et al.
Publicado: (2021)

GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries
por: Kozłowska, Hanna, et al.
Publicado: (2022)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
por: Dahal, Bhola K, et al.
Publicado: (2011)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats
por: Gao, Hanhua, et al.
Publicado: (2012)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats
por: Chang, Chao-Yuan, et al.
Publicado: (2019)

Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment
por: Hong, Young Mi, et al.
Publicado: (2014)

Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension
por: Zhu, Zhongkai, et al.
Publicado: (2020)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
por: Ding, Mingge, et al.
Publicado: (2015)

Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020)

Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol
por: Biernacki, Michał, et al.
Publicado: (2021)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Nicorandil Attenuates Monocrotaline-Induced Vascular Endothelial Damage and Pulmonary Arterial Hypertension
por: Sahara, Makoto, et al.
Publicado: (2012)

Microtubule proliferation in right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension
por: Stones, Rachel, et al.
Publicado: (2013)

Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension
por: Zhang, Wei-hua, et al.
Publicado: (2014)

Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung
por: Rafikova, Olga, et al.
Publicado: (2016)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats: Erratum
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kgj94herbv60ur1auaufvtvu6r